Ray Dalio Davita Inc. Transaction History

Bridgewater Associates, LP

$23.3 Billion
Q2 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Davita Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 112,107 shares of DVA stock, worth $14.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

112,107

Previous 228,272 50.89%

Holding current value

$14.4 Million

Previous $34.9 Million 54.27%

% of portfolio

0.07%

Previous 0.17%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$133.5 - $155.51 $15.5 Million - $18.1 Million	-116,165 Reduced 50.89%	112,107 $16 Million
Q1 2025 May 14, 2025	SELL	$140.0 - $177.35 $1.64 Million - $2.07 Million	-11,698 Reduced 4.87%	228,272 $34.9 Million
Q4 2024 Feb 13, 2025	BUY	$139.81 - $167.96 $25.1 Million - $30.2 Million	179,744 Added 298.45%	239,970 $35.9 Million
Q3 2024 Nov 13, 2024	SELL	$133.98 - $165.19 $2.74 Million - $3.38 Million	-20,472 Reduced 25.37%	60,226 $9.87 Million
Q2 2024 Aug 14, 2024	BUY	$126.11 - $147.14 $2.65 Million - $3.1 Million	21,047 Added 35.28%	80,698 $11.2 Million
Q1 2024 May 14, 2024	SELL	$103.89 - $139.21 $5.32 Million - $7.13 Million	-51,204 Reduced 46.19%	59,651 $8.23 Million
Q4 2023 Feb 14, 2024	SELL	$73.2 - $108.8 $161,991 - $240,774	-2,213 Reduced 1.96%	110,855 $11.6 Million
Q3 2023 Nov 13, 2023	BUY	$94.53 - $112.68 $2 Million - $2.38 Million	21,148 Added 23.01%	113,068 $10.7 Million
Q2 2023 Aug 11, 2023	BUY	$81.58 - $100.93 $1.48 Million - $1.83 Million	18,171 Added 24.64%	91,920 $9.24 Million
Q1 2023 May 12, 2023	SELL	$74.68 - $85.82 $2.48 Million - $2.85 Million	-33,201 Reduced 31.04%	73,749 $5.98 Million
Q4 2022 Feb 13, 2023	SELL	$65.42 - $99.31 $11.9 Million - $18.1 Million	-182,589 Reduced 63.06%	106,950 $7.99 Million
Q3 2022 Nov 10, 2022	BUY	$80.24 - $95.27 $2.54 Million - $3.02 Million	31,714 Added 12.3%	289,539 $24 Million
Q2 2022 Aug 11, 2022	BUY	$76.05 - $123.38 $10.6 Million - $17.2 Million	139,248 Added 117.43%	257,825 $20.6 Million
Q1 2022 May 13, 2022	BUY	$108.37 - $120.0 $3.74 Million - $4.14 Million	34,532 Added 41.09%	118,577 $13.4 Million
Q4 2021 Feb 14, 2022	SELL	$94.5 - $116.95 $1.74 Million - $2.16 Million	-18,439 Reduced 17.99%	84,045 $9.56 Million
Q3 2021 Nov 12, 2021	BUY	$116.26 - $133.78 $8.01 Million - $9.22 Million	68,918 Added 205.32%	102,484 $11.9 Million
Q2 2021 Aug 13, 2021	BUY	$105.44 - $127.98 $3.54 Million - $4.3 Million	33,566 New	33,566 $4.04 Million
Q3 2020 Nov 13, 2020	SELL	$79.57 - $91.84 $352,892 - $407,310	-4,435 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$65.52 - $88.28 $162,358 - $218,757	-2,478 Reduced 35.85%	4,435 $351,000
Q1 2020 May 14, 2020	BUY	$64.99 - $88.5 $449,275 - $611,800	6,913 New	6,913 $526,000
Q4 2019 Feb 13, 2020	SELL	$54.2 - $75.03 $39.4 Million - $54.6 Million	-727,788 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$52.55 - $63.28 $32.3 Million - $38.9 Million	614,825 Added 544.27%	727,788 $41.5 Million
Q2 2019 Aug 13, 2019	SELL	$43.42 - $57.79 $13.7 Million - $18.2 Million	-315,112 Reduced 73.61%	112,963 $6.36 Million
Q1 2019 May 14, 2019	SELL	$49.95 - $59.21 $1.58 Million - $1.87 Million	-31,658 Reduced 6.89%	428,075 $23.2 Million
Q4 2018 Feb 13, 2019	BUY	$48.73 - $76.08 $13.1 Million - $20.5 Million	269,579 Added 141.77%	459,733 $23.7 Million
Q3 2018 Nov 13, 2018	SELL	$66.51 - $74.55 $2.19 Million - $2.46 Million	-32,970 Reduced 14.78%	190,154 $13.6 Million
Q1 2018 May 15, 2018	BUY	$65.0 - $80.03 $14.5 Million - $17.9 Million	223,124 New	223,124 $14.7 Million
Q4 2017 Feb 13, 2018	SELL	$53.89 - $72.36 $19.1 Million - $25.6 Million	-354,456 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$56.13 - $64.78 $19.9 Million - $23 Million	354,456	354,456 $21.1 Million

Others Institutions Holding DVA

# of Institutions

676

Shares Held

70.6M

Call Options Held

776K

Put Options Held

1.13M

View Full List

About DAVITA INC.

Ticker DVA
Exchange NYSE
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 91,300,000
Market Cap $11.7B
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...

More about DVA

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account